Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (332,014)	$ (297,855)
Adjustments to reconcile net loss to net cash used for operating activities:
Amortization and depreciation		1,186
Loss on sales of marketable securities		170,766
Changes in operating assets and liabilities:
(Increase) decrease in prepaid expenses and other current assets	(22,423)	14,248
(Increase) decrease in deferred charges	922	922
Increase (decrease) in accounts payable and accrued expenses	(14,621)	(621,949)
Increase in accrued interest payable	1,115	110,639
Increase (decrease) in deferred revenue	(18,429)	(18,432)
Increase in current liabilities		(60,126)
Net cash used for operating activities	(385,450)	(700,601)
Cash flows from investing activities:
Sales and maturities of marketable securities		726,934
Net cash provided by investing activities		726,934
Cash flows from financing activities:
Advances from related party		50,000
Proceeds from issuance of promissory notes	365,000
Net cash provided by financing activities	365,000	50,000
Net (decrease) increase in cash and cash equivalents	(20,450)	76,333
Cash and cash equivalents, beginning of period	113,958	16,528
Cash and cash equivalents, end of period	93,508	92,861
Supplemental cash flow disclosures:
Net change in unrealized holding gains and losses	(20,990)
Accretion of Series F Preferred Stock	(5,294)
Accrued interest recognized upon troubled debt restructuring currently due	$ (56,298)